CAS: 646502-53-6; 4-((S)-2-((S)-2-(6-(2,5-Dioxo-2,5-Dihydro-1H-Pyrrol-1-yl)Hexanamido)-3-Methylbutanamido)-5-Ureidopentanamido)Benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-Hydroxy-1-Phenylpropan-2-yl)Amino)-1-Methoxy-2-Methyl-3-Oxopropyl)Pyrrolidin-1-

结构式图片

欧盟法规

C&L通报

合成工艺路线路线简述

    专利信息


    专利号:US-2017283878-A1
    优先权日:2015-12-11
    标题:Modulation of globoseries glycosphingolipid synthesis and cancer biomarkers
    发明人:WONG CHI-HUEY; WU CHUNG-YI; CHEUNG SARAH K C; CHUANG PO-KAI; HSU TSUI-LING
    权利人:ACADEMIA SINICA
    摘要:The present disclosure relates to methods and compositions which can modulate the globoseries glycosphingolipid synthesis. Particularly, the present disclosure is directed to glycoenzyme inhibitor compound and compositions and methods of use thereof that can modulate the synthesis of globoseries glycosphingolipid SSEA-3/SSEA-4/GloboH in the biosynthetic pathway; particularly, the glycoenzyme inhibitors target the alpha-4GalT; beta-4GalNAcT-I; or beta-3GalT-V enzymes in the globoseries synthetic pathway. Additionally, the present disclosure is also directed to vaccines, antibodies, and/or immunogenic conjugate compositions targeting the SSEA-3/SSEA-4/GLOBO H associated epitopes (natural and modified) which elicit antibodies and/or binding fragment production useful for modulating the globoseries glycosphingolipid synthesis. Moreover, the present disclosure is also directed to the method of using the compositions described herein for the treatment or detection of hyperproliferative diseases and/or conditions. Furthermore, the instant disclosure also relates to cancer stem cell biomarkers for diagnostic and therapeutic uses.

    专利号:WO-2024184661-A1
    优先权日:2023-03-09
    标 题 :Synthesis of bicycle toxin conjugates, and intermediates thereof
    发明人:LIMB DARREN; MOSS WILLIAM; WITTY DAVID; ZHANG JIE; LIN JINGUANG
    权利人:BICYCLETX LTD
    摘要:The present invention relates methods of preparing Bicycle toxin conjugates, and intermediates thereof.

    专利号:US-2024025947-A1
    优先权日:2021-03-31
    标题 :Preparation and purification process of monomethyl auristain e compound
    发明人:LI ZHUANGLIN; GUO WEI; SUN PENG; XIAO KAI; LI XINLI
    权利人:REMEGEN CO LTD
    摘要:Provided is a preparation and purification process of MMAE. The process has mild synthesis and purification conditions, can effectively prevent the change of product chirality caused by excessively high temperature, greatly reduces generation of degradation impurities, and increases the purity and yield of the product. In addition, the preparation and purification process has good stability and is more suitable for scale-up production. The MMAE prepared has purity of higher than 99%, and can perfectly meet clinical drug requirements.

    专利号:US-2025073339-A1
    优先权日:2023-08-15
    标 题 :Conjugates comprising cleavable linkers
    发明人:BEADLE JONATHAN DAVID; GALAN COCA ALBANO; COCCO MATTIA; GOUNDRY WILLIAM ROBERT FRASER
    权利人:ASTRAZENECA AB
    摘要:The specification relates to conjugates comprising a linker of Formula (IMA): n n n n n n n n n n and pharmaceutically acceptable salts thereof. The specification also relates the use of the conjugates for the treatment of diseases such as cancer, and intermediates useful for the synthesis of the conjugates.

    专利号:US-2025170267-A1
    优先权日:2022-02-28
    标 题 :Antibody-drug conjugate precursor and intermediate for synthesis thereof
    发明人:TSUZAKI YASUNORI; MIZUNO GEN; KASHIWAGI TAKAMASA; TANAKA MASAYUKI; SHIMIZU HAYATO; NONOUCHI SHIMPEI; MATSUSHITA TAKASHI; KIMURA TOMIO
    权利人:UBE CORP
    摘要:A method for improving the stability of an antibody-drug conjugate in a living body, and a conjugate precursor for producing a stabilized antibody-drug conjugate. An antibody-drug conjugate precursor represented by the following general formula (I) or a salt thereof, a synthetic intermediate thereof or a salt thereof, n Z-L-D  (I)n n where Z is a reactive group which can react with a functional group present in an antibody or a modified antibody; D is an antitumor drug residue in which one hydrogen atom or one hydroxy group is removed from any position of an antitumor drug molecule or an analog thereof or a derivative thereof; L is a linker which links Z to D; and at least any one of D and L has one or more lactonyl group(s) at any position(s) as substituent(s) or protecting group(s).

    专利号:US-2022047711-A1
    优先权日:2018-12-10
    标题 :Photocrosslinking peptides for site specific conjugation to fc-containing proteins
    发明人:SADOWSKY JACK; ZACHARIAS NEELIE TYANA
    权利人:GENENTECH INC
    摘要:Provided herein are peptides having a photocrosslinking moiety useful for the synthesis of antibody-drug conjugates as well as methods of making and using such conjugates.
    山东兄弟科技股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.oceanchemical.com
    电话: 0536-5456769👤
    📞山东兄弟科技股份有限公司 ⚠️参考联系方式

    销售电话:0536-5456769
    邮箱:ocean@oceanchemical.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Francisco JA, Cerveny CG, Meyer DL, Mixan BJ, Klussman K, Chace DF, Rejniak SX, Gordon KA, DeBlanc R, Toki BE, Law CL, Doronina SO, Siegall CB, Senter PD, Wahl AF. cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity. Blood. 2003 Aug 15;102(4):1458-65. doi: 10.1182/blood-2003-01-0039. Epub 2003 Apr 24. 21(7):1227-1235. doi: 10.1158/1535-7163.MCT-22-0013. 71(3):444-52. doi: 10.1016/j.yrtph.2015.01.014. Epub 2015 Feb 7. 2006–. Brentuximab Vedotin. 2023 Nov 15. 2006–. Polatuzumab Vedotin. 2023 Nov 15. 28(3):253-63. doi: 10.1007/s40259-014-0085-2.
    421:115534. doi: 10.1016/j.taap.2021.115534. Epub 2021 Apr 20. 26(11):4996. doi: 10.3390/ijms26114996.
    9: Poźniak M, Porębska N, Krzyścik MA, Sokołowska-Wędzina A, Jastrzębski K, Sochacka M, Szymczyk J, Zakrzewska M, Otlewski J, Opaliński Ł. The cytotoxic conjugate of highly internalizing tetravalent antibody for targeting FGFR1-overproducing cancer cells. Mol Med. 2021 May 7;27(1):46. doi: 10.1186/s10020-021-00306-2.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知